CRANBURY, N.J.--(BUSINESS WIRE)--May 24, 2006--Valera Pharmaceuticals, Inc. (NASDAQ: VLRX - News), a specialty pharmaceutical company focused on commercializing products for the urology and endocrinology markets, today announced the appointment of Jeremy D. Middleton to the newly created position of Vice President, Business Development.
